Options for Raising Capital in a Down Market

4:15 PM - 5:15 PM (PDT), Tuesday, June 14, 2022 ・ Upper Level, Session Room 6D

The current stock market environment for small biotechs is tough even by historical standards.  Many biotechs are now trading below cash value and IPOs have slowed significantly.  In the current environment, companies are having to consider alternative methods for raising capital to advance clinical trials and R&D pipelines.  This panel will discuss some of these specialized financing mechanisms, such as private investments in public entities (PIPEs), royalty deals, and other structured deals that use pipelines as collateral.